Skip to main content

Table 4 Association between gene polymorphisms of hypoxia-related genes and the mean SUVmax in patients with squamous cell carcinoma (n = 78)

From: The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients

Genes

Genotype

SUVmax

P*

Domonant model

SUVmax

P †

Recessive mode

SUVmax

P †

SLC2A1 -2841A>T

AA (n = 41)

9.40 ± 2.63

0.155

AA

9.40 ± 2.63

0.565

AA + AT

9.07 ± 2.79

0.130

 

AT (n = 29)

8.60 ± 2.98

 

AT + TT

9.04 ± 2.94

 

TT

10.64 ± 2.26

 
 

TT (n = 8)

10.64 ± 2.26

       

VEGFA +936C>T

CC (n = 54)

9.29 ± 2.66

0.816

CC

9.29 ± 2.66

0.774

CC + CT

9.20 ± 2.80

0.663

 

CT (n = 20)

8.95 ± 3.23

 

CT + TT

9.10 ± 3.06

 

TT

9.83 ± 2.25

 
 

TT (n = 4)

9.83 ± 2.25

       

APEX1 Asp148Glu

TT (n = 28)

8.89 ± 3.04

0.522

TT

8.89 ± 3.04

0.412

TT + TG

9.30 ± 2.90

0.672

 

TG (n = 34)

9.64 ± 2.79

 

TG + GG

9.43 ± 2.62

 

GG

8.97 ± 2.23

 
 

GG (n = 16)

8.97 ± 2.23

       

HIF1A Pro582Ser

CC (n = 69)

9.32 ± 2.84

0.671

      
 

CT (n = 10)

8.92 ± 2.35

       

HIF1A Ala588Thr

GG (n = 68)

9.18 ± 2.74

0.664

      
 

GA (n = 10)

9.59 ± 3.11

       
  1. *ANOVA † t-test